CONTROL-COVID

Control of Covid-19 outbreaks in Long Term Care

This is a placebo-controlled cluster-randomized trial to evaluate the efficacy of favipiravir for control of COVID-19 outbreaks in long-term care homes (LTCH). Read more...

STUDY 1: Favipiravir versus placebo for residents and LTCH staff

Protocol Short summary Q&A Documents in other languages Favipiravir Collaborators

Study is sponsored by Appili Therapeutics.

Introduction to study by Dr. Allison McGeer

Information for LTC Residents

Below you will find links to information for LTCH residents, their families and substitute decision makers.

Information for LTC staff

Below are links to information for LTC employees considering participation in CONTROL COVID Study.

Other study documents

Links to other study documents.

CONTROL-COVID: Control of Covid-19 outbreaks in long term care

COVID-19 studies for hospital and healthcare staff

COVID-19 study in teachers & other school personnel (CCS-2)

Étude COVID-19 chez les enseignants et autres personnels scolaires (CCS-2)

Immunogenicity of COVID-19 Vaccines in Long Term Care (CovidAB)

CONTROL-COVID: Primer on COVID-19

CONTROL-COVID: Favipiravir

Latest COVID-19 news update

World Health Organization

Government of Canada

Public Health Ontario

Video

How to collect a nasal swab

How to wash your hands - Public Health Ontario

How to do a hand rub - Public Health Ontario

Personal tools

CONTROL-COVID

CONTROL-COVID: Primer on COVID-19

CONTROL-COVID: Favipiravir

Video

Information for Control COVID study team